Eastern Bank’s Neurogene NGNE Stock Holding History

Eastern Bank’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.39K	Buy	+50	New	+$1.78K	﹤0.01%	1046

Other funds holding NGNE

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Eastern Bank's NGNE Position: Q3 2026 in Review

Eastern Bank opened a new position in Neurogene (NGNE) in Q3 2026: 50 shares worth $1.39K. The stake represents ﹤0.01% of the portfolio and ranks #1046 among its holdings.

11 funds tracked by Wall St. Rank hold NGNE as of Q3 2026.

Eastern Bank held 50 shares of Neurogene worth $1.39K as of Q3 2026.
Neurogene was a new Eastern Bank position in Q3 2026.
Neurogene made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #1046 holding.
11 funds tracked by Wall St. Rank held Neurogene as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.